Radiation first strategy aims to keep lung cancer at bay longer
NCT ID NCT06305715
Summary
This study is testing whether giving radiation to the main lung tumor before starting targeted drug therapy can help delay cancer progression in patients with advanced lung cancer that has specific genetic changes. The trial will enroll 34 patients who haven't had previous treatment for their metastatic lung cancer. Participants will receive radiation followed by standard targeted medications, with researchers tracking how long the cancer remains controlled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Froedtert Hospital & the Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.